As’ad E. Bhorat

8.6k total citations
5 papers, 88 citations indexed

About

As’ad E. Bhorat is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, As’ad E. Bhorat has authored 5 papers receiving a total of 88 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Virology and 2 papers in Epidemiology. Recurrent topics in As’ad E. Bhorat's work include HIV Research and Treatment (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and HIV/AIDS drug development and treatment (2 papers). As’ad E. Bhorat is often cited by papers focused on HIV Research and Treatment (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and HIV/AIDS drug development and treatment (2 papers). As’ad E. Bhorat collaborates with scholars based in United States, Romania and Belgium. As’ad E. Bhorat's co-authors include Reinilde Heyrman, Lydie Hazan, Ben Tao, Koichi Miyazaki, Alejandra Gurtman, Vani Sundaraiyer, Shabir A. Madhi, Daniel A. Scott, Emilio A. Emini and Beate Schmöele-Thoma and has published in prestigious journals such as Hypertension, AIDS and Journal of the International AIDS Society.

In The Last Decade

As’ad E. Bhorat

5 papers receiving 86 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
As’ad E. Bhorat United States	3	42	35	24	18	11	5	88
SR Choudhury India	4	20 0.5×	31 0.9×	18 0.8×	31 1.7×	10 0.9×	6	118
Alvin P. Chan United States	7	13 0.3×	4 0.1×	7 0.3×	23 1.3×	7 0.6×	15	95
Abdullah Al Shafi Majumder Bangladesh	2	14 0.3×	78 2.2×	18 0.8×	14 0.8×	2 0.2×	15	116
Aminda De Silva United Kingdom	7	18 0.4×	3 0.1×	14 0.6×	35 1.9×	3 0.3×	14	108
Sunita Ramanand India	5	10 0.2×	12 0.3×	16 0.7×	2 0.1×	7 0.6×	19	66
Golubinka Boševska North Macedonia	6	58 1.4×	9 0.3×	11 0.5×		5 0.5×	15	106
Sivanthiny Sivanandamoorthy France	3	46 1.1×	5 0.1×	32 1.3×	9 0.5×		6	117
Bernard Gitura Kenya	5	15 0.4×	45 1.3×	3 0.1×	3 0.2×	4 0.4×	8	79
George LL Machado‐Coelho Brazil	3	20 0.5×	5 0.1×	9 0.4×	6 0.3×	7 0.6×	3	87
Thomas H. Hunter Switzerland	5	50 1.2×	8 0.2×	13 0.5×	7 0.4×	5 0.5×	9	110

Countries citing papers authored by As’ad E. Bhorat

Since Specialization

Citations

This map shows the geographic impact of As’ad E. Bhorat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by As’ad E. Bhorat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites As’ad E. Bhorat more than expected).

Fields of papers citing papers by As’ad E. Bhorat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by As’ad E. Bhorat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by As’ad E. Bhorat. The network helps show where As’ad E. Bhorat may publish in the future.

Co-authorship network of co-authors of As’ad E. Bhorat

This figure shows the co-authorship network connecting the top 25 collaborators of As’ad E. Bhorat. A scholar is included among the top collaborators of As’ad E. Bhorat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with As’ad E. Bhorat. As’ad E. Bhorat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Bhorat, Qasim & As’ad E. Bhorat. (2021). A qualitative analysis of seven ivermectin formulations in South Africa. South African Medical Journal. 111(4). 288–288. 1 indexed citations

2.

Arathoon, Eduardo, As’ad E. Bhorat, Herta Crauwels, et al.. (2017). Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial. SAGE Open Medicine. 5. 2103758482–2103758482. 1 indexed citations

3.

Bhorat, As’ad E., Shabir A. Madhi, Vani Sundaraiyer, et al.. (2015). Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination. AIDS. 29(11). 1345–1354. 43 indexed citations

4.

Arathoon, Eduardo, As’ad E. Bhorat, Herta Crauwels, et al.. (2014). Week 48 results of a Phase IV trial of etravirine with antiretrovirals other than darunavir/ritonavir in HIV‐1‐infected treatment‐experienced adults. Journal of the International AIDS Society. 17(4S3). 19783–19783. 2 indexed citations

5.

Hazan, Lydie, et al.. (2010). A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension. Hypertension. 55(6). 1323–1330. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact